METHODS USING A COMBINATION OF A 3-HETEROARYL-2-INDOLINONE AND A CYCLOOXYGENASE-2 INHIBITOR FOR THE TREATMENT OF NEOPLASIA

Details for Australian Patent Application No. 2003239494 (hide)

Owner PHARMACIA CORPORATION

Inventors CHERRINGTON, Julie, M.; LEAHY, Kathleen, M.; ZWEIFEL, Ben, S.; MASFERRER, Jaime, L.

Pub. Number AU-A-2003239494

PCT Number PCT/US03/15582

PCT Pub. Number WO2003/097044

Priority 10/150,546 16.05.02 US

Filing date 15 May 2003

Wipo publication date 2 December 2003

International Classifications

A61K 031/4045

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 10/150,546 16.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003239494

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003239495-METHOD AND APPARATUS FOR A MULTIPLE MODULATION TRANSMITTER

2003239493-PARTICLE SEPARATION/PURIFICATION SYSTEM, DIFFUSER AND RELATED METHODS